ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA/ROCK1 and ERK/NF-κB signaling.

Rohan Bhadange et al.PubMed ↗Publisher ↗

No numbers read from the abstract.